MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF

Area of Science:

• Oncology
• Molecular Biology
• MicroRNA Research

Background:

• MicroRNAs (miRNAs) play crucial roles in cancer development, including tumor initiation, progression, and metastasis.
• While miR-217 dysregulation is noted in various cancers, its specific role in cutaneous squamous cell carcinoma (cSCC) is not well-understood.

Purpose of the Study:

• To investigate the expression and functional role of miR-217 in the development of cutaneous squamous cell carcinoma (cSCC).
• To identify the molecular targets and mechanisms underlying miR-217's function in cSCC.

Main Methods:

• Quantitative real-time PCR to assess miR-217 and PTRF expression in cSCC tissues and cell lines.
• Cell-based assays to evaluate the effects of miR-217 overexpression on cSCC cell proliferation, cell cycle, and invasion.
• Luciferase reporter assays and Western blotting to confirm PTRF as a direct target of miR-217.
• Rescue experiments to validate the functional significance of the miR-217/PTRF axis.

Main Results:

• miR-217 expression was significantly upregulated in cSCC tissues and cell lines compared to normal controls.
• Overexpression of miR-217 enhanced cSCC cell growth, promoted cell cycle progression, and increased cellular invasion.
• Polymerase I and Transcript Release Factor (PTRF) was identified as a direct target of miR-217 and its expression was downregulated in cSCC.
• A significant inverse correlation was observed between miR-217 and PTRF levels in cSCC samples.
• Restoring PTRF expression counteracted the oncogenic effects of miR-217 in cSCC cells.

Conclusions:

• Upregulation of miR-217 contributes to the pathogenesis of cSCC.
• The oncogenic function of miR-217 in cSCC is mediated, at least in part, by the suppression of its direct target gene, PTRF.
• miR-217 represents a potential therapeutic target for cutaneous squamous cell carcinoma.